Cargando…
Evaluating real-world COVID-19 vaccine effectiveness using a test-negative case–control design
Aim: It is important to assess if clinical trial efficacy translates into real-world effectiveness for COVID-19 vaccines. Materials & methods: We conducted a modified test-negative design (TND) to evaluate the real-world effectiveness of three COVID-19 vaccines. We defined cases in two ways: sel...
Autores principales: | Reynolds, Matthew W, Secora, Alex, Joules, Alice, Albert, Lisa, Brinkley, Emma, Kwon, Tom, Mack, Christina, Toovey, Stephen, Dreyer, Nancy A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504802/ https://www.ncbi.nlm.nih.gov/pubmed/36148919 http://dx.doi.org/10.2217/cer-2022-0069 |
Ejemplares similares
-
How frequent are acute reactions to COVID-19 vaccination and who is at risk?
por: Dreyer, Nancy, et al.
Publicado: (2022) -
COVID-19 Vaccination Breakthrough Infections in a Real-World Setting: Using Community Reporters to Evaluate Vaccine Effectiveness
por: Reynolds, Matthew W, et al.
Publicado: (2022) -
Identification of a Vulnerable Group for Post-Acute Sequelae of SARS-CoV-2 (PASC): People with Autoimmune Diseases Recover More Slowly from COVID-19
por: Dreyer, Nancy, et al.
Publicado: (2021) -
Self-reported symptoms from exposure to Covid-19 provide support to clinical diagnosis, triage and prognosis: An exploratory analysis
por: Dreyer, Nancy A., et al.
Publicado: (2020) -
Cognitive and other neuropsychiatric symptoms in COVID-19: analysis of person-generated longitudinal health data from a community-based registry
por: Largent, Joan, et al.
Publicado: (2023)